1. Background
2. Objectives
3. Methods
3.1. Participants
3.2. Carotid Ultrasound and Laboratory Examinations
4. Results
4.1. Demographic Features and Clinical Data of the Participants
| Variable | Total | Male | Female | P Value |
|---|---|---|---|---|
| Number | 66 (100.0) | 44 (66.7) | 22 (33.3) | 0.077 |
| Age, y | 10.73 ± 2.48 | 10.83 ± 2.79 | 10.55 ± 1.74 | 0.669 |
| Body mass index, kg/m2 | 24.78 ± 4.10 | 25.39 ± 4.40 | 23.56 ± 3.17 | 0.089 |
| Systolic blood pressure, mmHg | 118.69 ± 13.12 | 119.91 ± 13.88 | 116.32 ± 11.41 | 0.300 |
| Diastolic blood pressure, mmHg | 73.32 ± 10.00 | 74.91 ± 10.61 | 70.23 ± 8.04 | 0.074 |
| Total cholesterol, mg/dL | 168.59 ± 23.91 | 168.89 ± 27.48 | 168.00 ± 14.92 | 0.866 |
| High-density lipoprotein cholesterol, mg/dL | 48.32 ± 10.75 | 48.05 ± 10.53 | 48.86 ± 11.40 | 0.773 |
| Low-density lipoprotein cholesterol, mg/dL | 112.41 ± 24.23 | 112.86 ± 27.91 | 111.50 ± 14.88 | 0.797 |
| Triglyceride, mg/dL | 125.00 ± 63.44 | 125.39 ± 60.06 | 124.23 ± 71.21 | 0.945 |
| Oral glucose tolerance test | ||||
| 0 min, mg/dL | 91.13 ± 22.51 | 93.70 ± 26.59 | 85.86 ± 7.77 | 0.193 |
| 30 min, mg/dL | 144.64 ± 55.47 | 149.83 ± 65.90 | 133.74 ± 17.85 | 0.302 |
| 60 min, mg/dL | 162.59 ± 120.21 | 153.80 ± 73.54 | 181.11 ± 185.22 | 0.420 |
| 90 min, mg/dL | 133.54 ± 57.94 | 138.83 ± 69.09 | 122.42 ± 16.84 | 0.314 |
| 120 min, mg/dL | 129.97 ± 61.39 | 135.10 ± 73.52 | 119.16 ± 15.92 | 0.356 |
| Hemoglobin A1c, % | 5.69 ± 0.97 | 5.69 ± 0.97 | 5.49 ± 0.16 | 0.260 |
| Carotid intima-media thickness, mm | ||||
| Right | 0.425 ± 0.043 | 0.420 ± 0.033 | 0.436 ± 0.057 | 0.250 |
| Left | 0.415 ± 0.062 | 0.421 ± 0.039 | 0.404 ± 0.093 | 0.428 |
aData are presented as mean ± standard deviation or number (percentage).
4.2. Relationship Between the CIMT and Clinical Data
| Variable | Mean | Right | Left | ||
|---|---|---|---|---|---|
| Correlation Coefficient | P Value | Correlation Coefficient | P Value | ||
| Age, y | 10.73 ± 2.48 | 0.137 | 0.273 | 0.065 | 0.607 |
| Body mass index, kg/m2 | 24.78 ± 4.10 | 0.092 | 0.464 | 0.216 | 0.081 |
| Systolic blood pressure, mmHg | 118.69 ± 13.12 | -0.031 | 0.804 | -0.075 | 0.553 |
| Diastolic blood pressure, mmHg | 73.32 ± 10.00 | 0.039 | 0.756 | -0.081 | 0.522 |
| Total cholesterol, mg/dL | 168.59 ± 23.91 | 0.001 | 0.993 | 0.010 | 0.937 |
| High-density lipoprotein cholesterol, mg/dL | 48.32 ± 10.75 | -0.049 | 0.694 | -0.283 | 0.021 |
| Low-density lipoprotein cholesterol, mg/dL | 112.41 ± 24.23 | 0.032 | 0.796 | 0.055 | 0.661 |
| Triglyceride, mg/dL | 125.00 ± 63.44 | -0.008 | 0.950 | 0.061 | 0.624 |
| Oral glucose tolerance test (Fasting blood glucose) | |||||
| 0 min, mg/dL | 91.13 ± 22.51 | 0.167 | 0.187 | 0.266 | 0.034 |
| 30 min, mg/dL | 144.64 ± 55.47 | 0.009 | 0.945 | 0.170 | 0.199 |
| 60 min, mg/dL | 162.59 ± 120.21 | 0.071 | 0.591 | 0.075 | 0.570 |
| 90 min, mg/dL | 133.54 ± 57.94 | 0.150 | 0.257 | 0.318 | 0.014 |
| 120 min, mg/dL | 129.97 ± 61.39 | 0.108 | 0.413 | 0.336 | 0.009 |
| PGΔ30, mg/dL | - | -0.066 | 0.621 | 0.057 | 0.669 |
| PGΔ60, mg/dL | - | 0.043 | 0.749 | 0.020 | 0.879 |
| PGΔ90, mg/dL | - | 0.134 | 0.311 | 0.310 | 0.017 |
| PGΔ120, mg/dL | - | 0.074 | 0.579 | 0.338 | 0.009 |
| Hemoglobin A1c, % | 5.69 ± 0.97 | 0.151 | 0.236 | 0.306 | 0.015 |
| Carotid intima-media thickness, mm | |||||
| Right | 0.425 ± 0.043 | - | - | 0.382 | 0.002 |
| Left | 0.415 ± 0.062 | 0.382 | 0.002 | - | - |
Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; PG, plasma glucose.
4.3. Multiple Regression Analysis Between the Left CIMT and Metabolic Variables
Abbreviations: PG, plasma glucose; SE, standard error.
aLog-transformed values were used for analysis.
